TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors.
Sauer N, Janicka N, Szlasa W, Skinderowicz B, Kołodzińska K, Dwernicka W, Oślizło M, Kulbacka J, Novickij V, Karłowicz-Bodalska K.
Sauer N, et al.
Cancer Immunol Immunother. 2023 Nov;72(11):3405-3425. doi: 10.1007/s00262-023-03516-1. Epub 2023 Aug 11.
Cancer Immunol Immunother. 2023.
PMID: 37567938
Free PMC article.
Review.
Initially identified on the surface of T helper 1 (Th1) lymphocytes and later on cytotoxic lymphocytes (CTLs), monocytes, macrophages, natural killer cells (NKs), and dendritic cells (DCs), TIM-3 plays a key role in immunoregulation. Recently, a growing body of evidence ha …
Initially identified on the surface of T helper 1 (Th1) lymphocytes and later on cytotoxic lymphocytes (CTLs), monocytes, macrophages, natur …